Palvella Therapeutics (PVLA) Revenue Growth (1y) (2015 - 2024)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 64.24% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 7.82% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 19.04% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 3,790.58% |
| 10 | Palvella Therapeutics | 1.47 Bn | 1.21 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | -97.26% |
| Sep 30, 2023 | 5,934.50% |
| Jun 30, 2023 | 478.29% |
| Mar 31, 2023 | -82.38% |
| Sep 30, 2022 | -90.73% |
| Jun 30, 2022 | 36.54% |
| Mar 31, 2022 | -15.48% |
| Dec 31, 2021 | 164.52% |
| Sep 30, 2021 | -5.31% |
| Jun 30, 2021 | -77.41% |
| Mar 31, 2021 | -1.97% |
| Dec 31, 2020 | -38.58% |
| Sep 30, 2020 | -80.58% |
| Jun 30, 2020 | 110.92% |
| Mar 31, 2020 | 55.19% |
| Dec 31, 2019 | 409.33% |
| Sep 30, 2019 | 81.33% |
| Jun 30, 2019 | -54.39% |
| Mar 31, 2019 | 105.80% |
| Dec 31, 2018 | -96.69% |
| Sep 30, 2018 | 112.50% |
| Jun 30, 2018 | 530.92% |
| Mar 31, 2018 | 209.16% |
| Dec 31, 2017 | 565.77% |
| Sep 30, 2017 | 400.25% |
| Jun 30, 2017 | 72.72% |
| Mar 31, 2017 | 7.73% |
| Dec 31, 2016 | 744.14% |
| Sep 30, 2016 | 89.34% |
| Jun 30, 2016 | 569.52% |
| Mar 31, 2016 | 472.85% |
| Sep 30, 2015 | 2,114.32% |
| Jun 30, 2015 | -77.05% |